On February 12, 2019 Diplomat Pharmacy, Inc. (NYSE: DPLO) executives reported that it will participate in four upcoming investor conferences (Press release, Diplomat Speciality Pharmacy, FEB 12, 2019, View Source [SID1234533256]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Brian Griffin, chairman and CEO, and Atul Kavthekar, chief financial officer, will represent the company at these events:

8th Annual SVB Leerink Global Healthcare Conference in New York: Feb. 27 at 9 a.m. ET
Raymond James 40th Annual Institutional Investors Conference in Orlando: March 4 at 4 p.m. ET
Cowen and Company 39th Annual Health Care Conference in Boston: March 11 at 1:30 p.m. ET
Barclays Global Healthcare Conference in Miami: March 14 at 8:30 a.m. ET

Live audio webcasts of each presentation will be available on the investor relations section of Diplomat’s website at ir.diplomat.is. Audio recordings will be available online for approximately 30 days following each presentation.